Open AccessProtecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment
Author(s) -
Richard Anthony,
Michael H. Cynamon,
Sven Hoffner,
Jim Werngren,
Alice L. den Hertog,
Dick van Soolingen
Publication year - 2017
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00258-17
Subject(s) - pyrazinamide , tuberculosis , multiple drug resistance , medicine , intensive care medicine , antibiotics , microbiology and biotechnology , mycobacterium tuberculosis , biology , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom